Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
2.455
+0.015 (0.61%)
Jul 1, 2025, 2:14 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Biocatalysts, Pharmaceutical Intermediates, and Codex Biocatalyst Panels and Kits | 42.91M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Research and Development | 27.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Performance Enzymes | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Performance Enzymes Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Novel Biotherapeutics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Novel Biotherapeutics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 20.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 13.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC | 13.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC Growth | -79.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA | 11.31M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Growth | -80.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Switzerland | 11.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ireland | 500.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas | 33.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Americas Growth | -99.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|